PN-232

N/A

Report date: 2023/01/04 14:01:34
NME

Base Information

Drug NamePN-232
Drug Alias NamePN-232JNJ75105186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 23 Receptor inhibitors
TargetsInterleukin 23 Receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProtagonist Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesJanssen Pharmaceutical Kk
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A